Press Releases
PharmaDiagnostics announces three new coupling methods for its SoPRano(TM) label-free platform
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today the launch of...
Articles
Can personalised medicine save the pharma sector?
Personalised medicine is making a comeback – but will it stick this time? It was supposed to be the great saviour of the pharma...
Articles
Utilising a CTMS to Create a Development Edge
As clinical trials become more globalised and complex, there is an increased need for investigators in all regions of the world, as well as...
Clinical Trials
Adocia reports positive phase I clinical results on HinsBet(R), a fast-acting human insulin
Adocia, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today positive results from its phase I...
Drug Research
InhibOx and COSMIC Discoveries align to deliver full service drug discovery offering
New service supports big pharma’s drive to outsourcing by offering highly sophisticated technologies for drug discovery chemistry with leading computer-aided drug design services. ...
News
Lilly Announces New Vice President of Oncology Research
Eli Lilly and Company announced that Greg Plowman, M.D., Ph.D., will lead Lilly's oncology research efforts as the vice president, oncology research and senior...
News
AstraZeneca initiates phase III clinical programme evaluating NKTR-118
AstraZeneca announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read